What a great brainstorm of ideas and common ground for collaborations in the field of Immunotherapy and Radiotherapy Combination. A big Thank you to the Forbeck Research Foundation for brining us together. 'The hope is to shorten the cancer research timetable.' WGFRF

Our paper on RT+CTLA4+CD40 in hard-to-treat tumors is out in Nature Communications! In-depth analysis of 4T1 tumors treated with RT+CTLA4 and demonstration of CD40 as best companion IO in this setting. Thanks to all co-authors and especially maud charpentier and Sandra Demaria!